HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 6,500 shares, a growth of 170.8% from the November 30th total of 2,400 shares. Based on an average daily volume of 11,300 shares, the days-to-cover ratio is currently 0.6 days.
HAVN Life Sciences Price Performance
HAVLF traded up $0.02 on Thursday, hitting $0.06. 6,005 shares of the company were exchanged, compared to its average volume of 5,798. The firm has a fifty day simple moving average of $0.06 and a two-hundred day simple moving average of $0.50. HAVN Life Sciences has a 12 month low of $0.04 and a 12 month high of $4.59.
Get
HAVN Life Sciences alerts:
About HAVN Life Sciences
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.
Featured Stories
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- Cal-Maine Posts Record Quarter, Remain CALM Income Investors
- Tesla Stock: What the Bulls and the Bears Are Getting Wrong
- Big Health Care Stocks to Watch in the New Year
- The Top Three Stocks Analysts Say To Buy
- Can Dick's Sporting Goods Stock Score Another Win In Q4?
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
HAvn Life Science Inc.(场外交易市场代码:HAVLF-GET Rating)是空头股数12月份实现大幅增长的接受者。截至15日,空头股数共有6,500股,较11月30日的2,400股增长170.8。以日均成交量11,300股计算,目前天数与回补比率为0.6天。
拥有生命科学的性价比
HAVLF周四上涨0.02美元,触及0.06美元。该公司股票成交量为6,005股,而其平均成交量为5,798股。该公司的50日简单移动均线切入位为0.06美元,200日简单移动均线切入位为0.50美元。HAvn Life Sciences的12个月低点为0.04美元,12个月高位为4.59美元。
到达
拥有生命科学学位警报:
关于HAVN生命科学
(获取评级)
HAVN生命科学公司是一家生物技术公司,从事从植物和真菌中提取的精神药理产品的研究和开发。该公司还专注于开发从植物和真菌(包括裸子菌属)中标准化和质量控制地提取精神活性化合物的方法。
专题报道
- 免费获取StockNews.com关于HAVN生命科学的研究报告(HAVLF)
- 加州缅因州公布创纪录的季度业绩,保持冷静的收入投资者
- 特斯拉股票:公牛和熊队哪里出了问题
- 新年值得关注的大型医疗保健类股
- 分析师认为最值得买入的三只股票
- Dick‘s Sports Goods Stock能否在第四季度再获胜利?
接受《HAVN生命科学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对HAVN生命科学和相关公司的最新新闻和分析师评级的每日简要摘要。